We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ipso Ventures | LSE:IPS | London | Ordinary Share | GB00B1GDWB47 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.425 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/11/2011 22:32 | Now the Pharmacies are all rolling it out too. NPA-National Pharmacy Association Documents. Buccolam (midazolam) oromucosal (buccal) solution 5mg/1ml has recently been granted a paediatric use marketing authorisation (PUMA) by the European Commission, and as such is now classed as a licensed product. The following FAQs will assist when deciding what product to supply against either a requisition or a prescription. | topinfo | |
22/11/2011 22:32 | Here we go, the evening pump and dump shift second gang member topinfo is here to spam more rubbish ! Strange how each time he does this he vanishes after a load of sales the next morning. Just testing here, is there anybody lurking that would buy this because of what well known pump and dumpers will paste here tonight. m4 and topinfo are conmen ! | kinghorm23 | |
22/11/2011 22:29 | Now here comes the real good stuff by way of a few hours further research on IPS this evening. Now we all know what Buccolam is used for and why it will become the drug that is prescribed now it has full EU approval. It is now licensed and the roll out to the NHS etc begins. MHRA Drug Safety Update (October 2011): Care needed when transferring from unlicensed formulations of buccal midazolam to licensed product (Buccolam) for paediatric use | topinfo | |
22/11/2011 22:17 | ps...your posts suggest you are seriously deranged and very paranoid m4 ! | kinghorm23 | |
22/11/2011 22:16 | It's sheer on ludicrous that you and topinfo have the arrogance to think you can come and come at will and pump and dump this stock when all your pump and dump posts are still splattered all over this thread. Honesty M4 i think you are absolute scum, the lowest parasite of them all to be part of a serial pump and dump group. | kinghorm23 | |
22/11/2011 12:36 | yep opened it tops thanks | moreforus | |
22/11/2011 12:34 | I cant seem to copy link so you have to get it by downloading it and opening it in Acrobat. Transfer to new Licensed Buccal Midazolam 5mg/ml (Buccolam ... www.elmmb.nhs.uk/Eas You +1'd this publicly. Undo File Format: PDF/Adobe Acrobat - View as HTML 4 days ago - Buccal midazolam (Buccolam▼) is a new licensed treatment for prolonged acute ... Buccolam is half the strength of some other unlicensed preparations. ... # Epilepsy - NeLM | topinfo | |
22/11/2011 12:30 | Thats Buccolam. If thats the NHS now using it, imagine royalties to Therakind! | topinfo | |
22/11/2011 12:25 | NHS Copy and paste that link www.elmmb.nhs.uk/Eas | topinfo | |
22/11/2011 12:25 | Just found some very interesting stuff out as well M4. | topinfo | |
22/11/2011 12:22 | The thing I notice about IPS is it needs a bombing before a good rise. Its had the bombing and here comes the rise again! | topinfo | |
18/11/2011 07:45 | No sign of the pump and dumpers now eh. News this morning, from the 1st but at 3.75p so it might give the share a lift, not sure. The Board of IPSO announces that it has today issued a total of 800,000 new ordinary shares of 0.1 pence each in IPSO (the "New Ordinary Shares") to the existing directors of IPSO and a former director in lieu of net fees payable for the three month period ended 31 October 2011. The New Ordinary Shares were issued at a price of 3.75 pence, being the closing mid-market price of IPSO's ordinary shares on 1 November 2011. | kinghorm23 | |
16/11/2011 22:39 | Normally the time to buy though, buy at 3p or less and sell at 4p or more on the next spike, usually sticks to that pattern. And any news would certainly help that as well. | kinghorm23 | |
16/11/2011 21:50 | Mooochy... it seems all the weak holders have exited.. only the optimists remain... let me guess... Fridays are a strong day... so not long to wait.... here we are ... sub 3p.... by the way I wouldnt pay £100 at this price... Cash is burning away...Anyone post about the reduction in FIT which will be a devastating blow for the Ipsol business.... nah... shares being shuffled.... it really isnt looking good now......... | electrick | |
16/11/2011 12:37 | MMs trying to shake weak holders out here so it would seem. | moochy | |
15/11/2011 10:03 | The change of registered office and now directors moving chunks of shares around to obviuosly create losses or if the shares shoot up match those gains with losses available elsewhere. You wouldn't do that if you thought something was a foot that would enable your plans to come to fruition. Is this good or bad? Who knows but if it is to move the potential wealth around the family then it is being done at a time when the shares and thus any capital gains created are at their lowest. If it it is being to to maximise the potential available tax losses as you know the compnay is a dead duck then we should all scarper as well. I think some good news is on the way and that is why things are being moved around. | fur | |
14/11/2011 14:56 | DJ Ipso Ventures PLC Director/PDMR Shareholding TIDMIPS RNS Number : 0514S Ipso Ventures PLC 14 November 2011 14 November 2011 IPSO Ventures plc ("IPSO" or the "Company") Director's dealing Holding in Company The Board of IPSO announces that Craig Rochford, Chairman of IPSO, sold 1,675,000 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") on 11 November 2011 to Buckton Homes Limited at a price of 1 pence per Ordinary Share in an off-market transaction (the "Share Transaction"). Buckton Homes Limited, a company wholly owned by the adult children of Fred Stirling, holds a total beneficial interest in 1,675,000 Ordinary Shares in the Company following the Share Transaction, equivalent to 4.45% of IPSO's total issued share capital. In addition, the Company was notified today that, on 11 November 2011, Craig Rochford transferred 50,000 Ordinary Shares held by Arka Technologies Limited, a company wholly owned by Craig Rochford, into his personal name in an off-market transaction at a price of 3.5 pence per Ordinary Share (the "Transfer"). Following the Share Transaction and the Transfer, Craig Rochford holds a total beneficial interest in 2,405,000 Ordinary Shares in the Company equivalent to 6.39 per cent. of IPSO's total issued share capital. 480,000 of the Ordinary Shares are held by The Invention Company Limited, a company wholly owned by Craig Rochford. For further information, please contact: | day7rader | |
10/11/2011 11:06 | Hi Nopolipo, to be honest I don't know that much about the plus market either. what I do know is that "PLUS is a London-based stock exchange providing cash trading and listing, derivatives and technology services. PLUS delivers product innovation and competitive pricing to market participants by operating a low cost base RIE. PLUS offers a neutral trading environment, wholly independent of any market user." This is quoted from their website-link below. | moochy | |
10/11/2011 07:50 | 3.38 close...... perhaps today will be the day for sub 3p | electrick |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions